gms | German Medical Science

60. Jahrestagung der Deutschen Gesellschaft für Neuropathologie und Neuroanatomie (DGNN)

Deutsche Gesellschaft für Neuropathologie und Neuroanatomie

26. - 28.08.2015, Berlin

Distinct morphology in molecular subgroups of glioblastoma in young patients

Meeting Abstract

Suche in Medline nach

  • corresponding author presenting/speaker Julia Pöschl - LMU München, Zentrum für Neuropathologie, München, Germany
  • Arend Koch - Charité Universitätsmedizin, Department of Neuropathology, Berlin, Germany
  • Armin Giese - LMU München, Zentrum für Neuropathologie, München, Germany
  • Ulrich Schüller - LMU München, Zentrum für Neuropathologie, München, Germany

Deutsche Gesellschaft für Neuropathologie und Neuroanatomie. 60th Annual Meeting of the German Society for Neuropathology and Neuroanatomy (DGNN). Berlin, 26.-28.08.2015. Düsseldorf: German Medical Science GMS Publishing House; 2015. Doc15dgnnP47

doi: 10.3205/15dgnn71, urn:nbn:de:0183-15dgnn711

Veröffentlicht: 25. August 2015

© 2015 Pöschl et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe



Introduction: Glioblastoma is a malignant primary brain tumor that occurs in all age groups and corresponds to WHO°IV. Based on genetics, global gene expression, and methylation patterns, glioblastoma can be categorized in six different molecular subgroups named “IDH”, “K27”, “G34”, “RTK I”, “Mesenchymal”, and “RTK II” (Sturm et al. 2012). ”IDH” glioblastomas, which carry mutations within IDH1 or IDH2 as well as the “K27” and “G34” subgroups, which are characterized by distinct mutations within the H3F3A gene, are particularly often found in younger patients below 30 years of age.

Objective: We aimed to analyze the histomorphology of glioblastoma found in younger patients with known molecular subgroups.

Patients & methods: Patients <30 years were included in the study. IDH1 R132H and H3F3A K27M mutation status was defined by immunohistochemistry and verified by pyrosequencing. Other IDH1 or IDH2 mutations, as well as H3F3A G34R mutations were analyzed by pyrosequencing.

Results: Besides disparities in cell density, cellular morphology and nuclear pleomorphism, we detected different extents of vessel proliferation and geographic or pseudopallisading necroses in the distinct molecular subgroups. Specifically, glioblastoma cases carrying H3F3A G34R mutations displayed a very undifferentiated morphology with densely packed cells and high nuclear pleomorphism. H3F3A K27M mutated cases more often showed necroses and commonly showed tumor cells with large and sometimes vacuolated nuclei. IDH mutated cases displayed lower cell density, an astroglial morphology and often harbored microcystic features or gemistocytic tumor cells.

Conclusions: Molecular glioblastoma subgroups are characterized by distinct histomorphological features that can be detected by routine histology. This underlines the diversity of glioblastoma and suggests that distinct morphological features reflect the underlying molecular changes.